Gene editing can sound like the stuff of science fiction, but a new technique may allow scientists to remove harmful genes from white blood cells and replace them with more beneficial material. The development carries the potential to open new avenues to treat conditions from HIV and lupus to cancer.
The research—led by Alexander Marson, MD, PhD, the scientific director of biomedicine at the Innovative Genomics Institute, a partnership between University of California, San Francisco and the University of California, Berkeley—explored a process of using electrical fields to modify genes. Rather than using viruses, scientists used a “CRISPR-Cas9 genome-targeting system that does not require viral vectors” that can streamline the editing process.
“We needed something targeted, something fast and something efficient,” Marson said, in an interview with The New York Times. “What if we could just paste in a piece of DNA and avoid the viruses altogether?”
Read more about the breakthrough and its potential implications at link below:
Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.